http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008132274-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98ea03ea82ddda1b5e19c818ea7c91f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f843b6a1c962b5cee5037d9a64ca37ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acb03ef40c3770d71356cba36a813f09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a3fe7ce85f9d38d5475d4be7ea9ed14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54
filingDate 2008-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ab232ac4518338e015572a8c712462f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_758aa1b232b951080e21593e5264e77e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb1f1e3af7202d7a784294cdcf1eac5
publicationDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008132274-A1
titleOfInvention Membrane shell of an implantable dosage system
abstract The membrane shell of an implantable dosage system according to the invention is particularly suitable for subcutaneous applications to release an active agent with steady amounts during a longer period of time. The membrane shell (3) according to the invention comprises a first half (1) and a second half (2), which both halves comprise a continuous closure edge (8, 9), and are adapted to be connected to each other through a closable joint. The closure edges (8, 9) of the halves comprise at least one groove (10) and/or at least one protrusion (11) as continuous or discontinuous, and the membrane shell (3) is adapted to be closed so that at least one protrusion (11) and/or at least one groove (10) of the second half becomes opposed to at least one groove (10) and/or at least one protrusion (11) of the first half through a snap-fit joint.
priorityDate 2007-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6508808-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006039459-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02053129-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135773241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123356593

Total number of triples: 30.